1. Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2-year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! Registry.

Gabrielle PH, Nguyen V, Creuzot-Garcher C, Miguel L, Alforja S, Sararols L, Casaroli-Marano RP, Zarranz-Ventura J, Gillies M, Arnold J, Barthelmes D.Acta Ophthalmol. 2021 May 6. doi: 10.1111/aos.14893. Online ahead of print.PMID: 33960115

2. Priming human adipose-derived mesenchymal stem cells for corneal surface regeneration.

Nieto-Nicolau N, Martínez-Conesa EM, Fuentes-Julián S, Arnalich-Montiel F, García-Tuñón I, De Miguel MP, Casaroli-Marano RP.J Cell Mol Med. 2021 May 5. doi: 10.1111/jcmm.16501. Online ahead of print.PMID: 33951289

3. Amniotic membrane extract eye drops for ocular surface diseases: use and clinical outcome in real-world practice.

Sabater-Cruz N, Figueras-Roca M, Ferrán-Fuertes M, Agustí E, Martínez-Conesa EM, Pérez-Rodríguez ML, Vilarrodona A, Casaroli-Marano RP; AMEED Study Group.Int Ophthalmol. 2021 Apr 17. doi: 10.1007/s10792-021-01856-4. Online ahead of print.PMID: 33864578

4. Publisher Correction: MLIP genotype as a predictor of pharmacological response in primary open-angle glaucoma and ocular hypertension.

Canut MI, Villa O, Kudsieh B, Mattlin H, Banchs I, González JR, Armengol L, Casaroli-Marano RP.Sci Rep. 2021 Apr 9;11(1):8237. doi: 10.1038/s41598-021-87653-6.PMID: 33837244 

5. Corneal transplantation activity in Catalonia, Spain, from 2011 to 2018: Evolution of indications and surgical techniques.

Sabater-Cruz N, Figueras-Roca M, Padró-Pitarch L, Tort J, Casaroli-Marano RP.PLoS One. 2021 Apr 8;16(4):e0249946. doi: 10.1371/journal.pone.0249946. eCollection 2021.PMID: 33831081

6. Twelve-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registry.

Hunt AR, Nguyen V, Creuzot-Garcher CP, Alforja S, Gabrielle PH, Zarranz-Ventura J, Guillemin M, Fraser-Bell S, Casaroli Marano RP, Arnold J, McAllister IL, O’Toole L, Gillies MC, Barthelmes D, Mehta H.Br J Ophthalmol. 2021 Mar 12:bjophthalmol-2020-318491. doi: 10.1136/bjophthalmol-2020-318491. Online ahead of print.PMID: 33712484

7. Eye bank and theatre factors for positive microbiological culture of corneoscleral rim and cornea storage medium in the real-world.

Sabater-Cruz N, Otero N, Dotti-Boada M, Ríos J, Gris O, Güell JL, Vilarrodona A, Casaroli-Marano RP.Eye (Lond). 2021 Jan 19. doi: 10.1038/s41433-020-01342-8. Online ahead of print.PMID: 33469128

8. MLIP genotype as a predictor of pharmacological response in primary open-angle glaucoma and ocular hypertension.

Canut MI, Villa O, Kudsieh B, Mattlin H, Banchs I, González JR, Armengol L, Casaroli-Marano RP.Sci Rep. 2021 Jan 15;11(1):1583. doi: 10.1038/s41598-020-80954-2.PMID: 33452295